The Sidney Kimmel Comprehensive Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Not Applicable
Completed
- Conditions
- Cancer
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Phase 2
Terminated
- Conditions
- Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-07-20
- Target Recruit Count
- 40
- Registration Number
- NCT00002778
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Phase 2
Completed
- Conditions
- Aplastic AnemiaParoxysmal Hemoglobinuria, Nocturnal
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2019-01-18
- Target Recruit Count
- 69
- Registration Number
- NCT00004464
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath